27.10.2014 Views

Balance Sheet at 31 December 2010 of BBVA

Balance Sheet at 31 December 2010 of BBVA

Balance Sheet at 31 December 2010 of BBVA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

individual shareholders with direct or indirect holdings gre<strong>at</strong>er than or equal to 3% <strong>of</strong> the <strong>BBVA</strong> common<br />

stock, except in the case <strong>of</strong> the Blackrock Inc. which on February 4, <strong>2010</strong>, reported to the Spanish Securities<br />

and Exchange Commission (CNMV) th<strong>at</strong>, as a result <strong>of</strong> the acquisition on <strong>December</strong> 1, 2009 <strong>of</strong> the Barclays<br />

Global Investors (BGI) business, it had an indirect holding <strong>of</strong> <strong>BBVA</strong> common stock totaling 4.45% through<br />

Blackrock Investment Management.<br />

<strong>BBVA</strong> is not aware <strong>of</strong> any direct or indirect interests through which ownership or control <strong>of</strong> the Bank may be<br />

exercised.<br />

<strong>BBVA</strong> has not been notified <strong>of</strong> the existence <strong>of</strong> any agreements between shareholders to regul<strong>at</strong>e the<br />

exercise <strong>of</strong> voting rights <strong>at</strong> the Bank’s AGMs, or to restrict or place conditions upon the free transferability <strong>of</strong><br />

<strong>BBVA</strong> shares. The Bank is also not aware <strong>of</strong> any agreement th<strong>at</strong> might result in changes in the control <strong>of</strong> the<br />

issuer.<br />

The AGM held on March 13, 2009, under the fifth point <strong>of</strong> the Agenda, resolved to confer authority on the<br />

Board <strong>of</strong> Directors, pursuant to article 153.1.b) <strong>of</strong> the Corpor<strong>at</strong>ions Act (now Article 297.1b) <strong>of</strong> the<br />

Corpor<strong>at</strong>ions Act), to resolve to increase the common stock on one or several occasions up to the maximum<br />

nominal amount representing 50% <strong>of</strong> the Company’s common stock th<strong>at</strong> is subscribed and paid up on the<br />

d<strong>at</strong>e on which the resolution is adopted, i.e., €918,252,434.60. Article 159.2 <strong>of</strong> the Corpor<strong>at</strong>ions Act (now<br />

Article 506 <strong>of</strong> the Corpor<strong>at</strong>ions Act) empowers the Board to exclude the pre-emptive subscription right in<br />

rel<strong>at</strong>ion to these share issues, although this power is limited to 20% <strong>of</strong> the Company’s share capital, under<br />

the terms and with the limit<strong>at</strong>ions <strong>of</strong> the aforementioned agreement. The directors have the legallyestablished<br />

time period during which to increase the common stock, i.e., five years from the d<strong>at</strong>e <strong>of</strong> the<br />

adoption <strong>of</strong> the resolution by the AGM on March 13, 2009.<br />

On the signing <strong>of</strong> this agreement, the Board <strong>of</strong> Directors agreed on a share capital increase <strong>of</strong> the Bank with<br />

the pre-emptive subscription right, as described above, on November 1, <strong>2010</strong>. The Board <strong>of</strong> Directors, <strong>at</strong> its<br />

meeting on July 27, 2009, agreed to a share capital increase for the amount required to address the<br />

conversion <strong>of</strong> the convertible oblig<strong>at</strong>ions agreed upon on said d<strong>at</strong>e, as described below. This will be carried<br />

out through the issue and release into circul<strong>at</strong>ion <strong>of</strong> up to 444,444,445 ordinary shares with a par value <strong>of</strong><br />

€0.49 each and without prejudice to the adjustments th<strong>at</strong> may arise according to the anti-dilution<br />

mechanisms.<br />

At the AGM held on March 14, 2008 the shareholders resolved to deleg<strong>at</strong>e to the Board <strong>of</strong> Directors for a<br />

five-year period the right to issue bonds, convertible and/or exchangeable into Bank shares for a maximum<br />

total <strong>of</strong> €9,000 million. The powers include the right to establish the different aspects and conditions <strong>of</strong> each<br />

issue, including the power to exclude the pre-emptive subscription right <strong>of</strong> shareholders in accordance with<br />

the Corpor<strong>at</strong>ions Act (now the Corpor<strong>at</strong>ions Act), to determine the basis and methods <strong>of</strong> conversion and to<br />

increase capital stock in the amount considered necessary. In virtue <strong>of</strong> said authoriz<strong>at</strong>ion, the Board <strong>of</strong><br />

Directors, <strong>at</strong> its meeting on July 27, 2009, agreed to proceed to the issue <strong>of</strong> convertible oblig<strong>at</strong>ions for an<br />

amount <strong>of</strong> €2,000 million with the exclusion <strong>of</strong> the right to pre-emptive subscription right (see Note 20), as<br />

well as the corresponding Bank’s share capital increase needed to address the conversion <strong>of</strong> said<br />

convertible oblig<strong>at</strong>ions, on the basis <strong>of</strong> the conferral to the Board <strong>of</strong> Directors to increase share capital, as<br />

adopted by the aforementioned AGM held on March 13, 2009.<br />

Previously, the AGM held on March 18, 2006 had agreed to deleg<strong>at</strong>e to the Board <strong>of</strong> Directors the faculty to<br />

issue, within a maximum legal period <strong>of</strong> five years as <strong>of</strong> said d<strong>at</strong>e, on one or several occasions, directly or<br />

through subsidiary companies fully underwritten by the Bank, any kind <strong>of</strong> debt instruments through<br />

debentures, any class <strong>of</strong> bonds, promissory notes, any class <strong>of</strong> commercial paper or warrants, which may be<br />

totally or partially exchangeable for equity th<strong>at</strong> the Company or another company may already have issued,<br />

or via contracts for difference (CFD), or any other senior or secured nomin<strong>at</strong>ive or bearer debt securities<br />

(including mortgage-backed bonds) in euros or any other currency th<strong>at</strong> can be subscribed in cash or kind,<br />

with or without the incorpor<strong>at</strong>ion <strong>of</strong> rights to the securities (warrants), subordin<strong>at</strong>ed or not, with a limited or<br />

open-ended term. The total maximum nominal amount authorized is €105,000 million. This amount was<br />

increased by €30,000 million by the Ordinary General Stockholders’ Meeting held on March 16, 2007, by<br />

€50,000 million by the AGM on March 14 2008, and by an additional €50,000 million by the AGM on March<br />

13, 2009. Accordingly, the maximum total nominal amount deleg<strong>at</strong>ed by the General Meeting was €235,000<br />

million.<br />

91

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!